News
More news
Featured Story
KU Researcher Finds Gene that Enhances Anti- Viral Immunity
Robin Orozco, an Immunologist at the University of Kansas, has unveiled new research that explores how a common mutation in the human population changes the immune response during a virus infection.
More news
NIH STARTUP Central Proof of Concept (POC) Project Awarded
Professor Liang Xu was awarded a NIH STARTUP Central Proof of Concept (POC) Program Award.
Six Students Receive Undergraduate Research Awards Mentored by MB Faculty Members
Six students received this semester an Undergraduate Research Award (UGRA) from the Center for Undergraduate Research to work on mentored research in the lab of a Molecular Biosciences faculty member.
Molecular Biosciences welcomes Maged Zeineldin to faculty
A medical researcher working to understand the epigenetics of cancer will join the University of Kansas faculty next fall as part of The Department of Molecular Biosciences and University of Kansas Cancer Center.
John C. (Jack) Brown, In Memoriam
John C. (Jack) Brown, In Memoriam, February 23, 1943 - October 9, 2023
Braden’s Hope Foundation Pilot Project Awarded
Mizuki Azuma was awarded a pilot grant from the Braden’s Hope Foundation.
Molecular Biosciences welcomes Hans Dalton to faculty
A scientist driven to understand and treat rare human diseases will join the University of Kansas faculty next fall, becoming part of a team using “big data” to discover new drugs.
RESEARCHERS SHED LIGHT ON HOW ONE DEADLY FUNGAL PATHOGEN MAKES ITS CHEMICALS
LAWRENCE — Investigators at the University of Kansas have played a key role in deciphering a previously unidentified cluster of genes responsible for producing sartorypyrones, a chemical made by the fungal pathogen Aspergillus fumigatus, whose family can cause a deadly infection in humans. Their…
NEW GRASP OF KEY COVID-19 PROTEIN MAY LEAD TO A LIVE-ATTENUATED VACCINE EFFECTIVE AGAINST MORE VARIANTS FOR LONGER
Research from the University of Kansas just published in Proceedings of the National Academy of Sciences could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
GRANT WILL FUND RESEARCH INTO ANTIBIOTIC RESISTANCE
Professor Joanna Slusky received a grant from the National Institute of General Medical Sciences (NIH NIGMS) to investigate antibiotic resistance.